Teva Pharmaceutical News
Most Popular Teva Pharmaceutical Story
Gloom for the pharma industry, yes. Doom? No
AstraZeneca's ($AZN) layoffs announcement yesterday touched off more than its share of hand-wringing. It may be a straw-that-broke-the-camel's-back case; this shedding of 7,300 jobs follows a spate Read more...
Latest Headlines
- February 3, 2012
- January 12, 2012
- January 4, 2012
- January 3, 2012
- December 22, 2011
- December 13, 2011
- December 8, 2011
- December 7, 2011
- December 2, 2011
- December 2, 2011
- November 18, 2011
- November 16, 2011
- November 14, 2011
- November 11, 2011
- November 8, 2011
- November 7, 2011
- November 4, 2011
- November 3, 2011
- November 3, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
